PuSH - Publication Server of Helmholtz Zentrum München

50 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
O'Leary, V.B. et al.: The long non-coding RNA PARTICLE is associated with WWOX and the absence of FRA16D breakage in Osteosarcoma patients. Oncotarget 8, 87431-87441 (2017)
2.
Ripperger, T.* et al.: Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am. J. Med. Genet. A 173, 1017-1037 (2017)
3.
Smida, J. et al.: Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma. Int. J. Cancer 141, 816-828 (2017)
4.
Engert, F.* ; Kovac, M.* ; Baumhoer, D.* ; Nathrath, M. & Fulda, S.*: Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics. Oncotarget 8, 48794-48806 (2016)
5.
Kovac, M.* et al.: Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat. Commun. 6:8940 (2015)
6.
Maugg, D. et al.: New small molecules targeting apoptosis and cell viability in osteosarcoma. PLoS ONE 10:e0129058 (2015)
7.
Nathrath, M. ; Smida, J. ; Baumhoer, D. & Kovac, M.*: The genomic landscape in osteosarcoma. Pediatr. Blood Cancer 62, S164 (2015)
8.
Poos, K.* et al.: Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules. PLoS ONE 10:e0123082 (2015)
9.
Ribi, S.* et al.: TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome. Oncotarget 6, 7727-7740 (2015)
10.
Arabi, L.* et al.: Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences. Genes Cancer 5, 56-63 (2014)
11.
Avitzur, Y.* et al.: Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. Gastroenterology 146, 1028-1039 (2014)
12.
Baumhoer, D. et al.: Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK registry. Oral Oncol. 50, 147-153 (2014)
13.
Poos, K.* et al.: Structuring osteosarcoma knowledge: An osteosarcoma-gene association database based on literature mining and manual annotation. Database 2014:bau042 (2014)
14.
Rosemann, M. et al.: A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice. Mol. Cancer 13:182 (2014)
15.
Dantonello, T.M.* et al.: Malignant ectomesenchymoma in children and adolescents: Report from the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr. Blood Cancer 60, 224-229 (2013)
16.
Dantonello, T.M.* et al.: Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma. Pediatr. Blood Cancer 60, 1267-1273 (2013)
17.
Icheva, V.* et al.: Adoptive transfer of Epstein-Barr Virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 31, 5-7 (2013)
18.
Icheva, V.* et al.: Adoptive transfer of Epstein-Barr Virus (EBV) nuclear antigen 1-specific T cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. J. Clin. Oncol. 31, 39-48 (2013)
19.
Poos, K.* et al.: How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation. PLoS Comput. Biol. 9:e1003210 (2013)
20.
Baumhoer, D. et al.: MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet. 205, 212-219 (2012)